Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down
Source: NASDAQ US Markets / 24 Feb 2022 03:43:25 America/New_York
(RTTNews) - Hikma Pharmaceuticals Plc. (HIK, HIK.L) reported Thursday that its fiscal 2021 profit attributable to shareholders dropped 2 percent to $421 million from last year's $431 million.
https://www.nasdaq.com/articles/hikma-pharma-fy21-profit-down-lifts-dividend-stock-down